Moderna’s Strategic Shift: From COVID-19 Vaccine Leader to mRNA Pipeline Diversification Moderna, Inc. (NASDAQ: MRNA) is currently recalibrating its business model as the global demand for COVID-19 vaccines stabilizes. Following …
Tag: